Zobrazeno 1 - 10
of 3 018
pro vyhledávání: ''
Autor:
Kritika, Krishnamurthy, Arunima, Deb, Sarah, Alghamdi, Michael, Schwartz, Mike, Cusnir, Vathany, Sriganeshan, Robert, Poppiti
Publikováno v:
Breast Disease. 41:295-301
BACKGROUND: Breast cancer, one of the leading causes of cancer-related mortality in women worldwide, exhibits wide-ranging histo-morphologic, clinical and molecular diversity. OBJECTIVE: This study compares the genetic alterations of breast tumors wi
Publikováno v:
Breast Disease. 41:273-278
BACKGROUND: Mondor disease is superficial thrombophlebitis of the thoracoabdominal wall, mid-upper arm, and penis. Although it is usually a benign disease requiring no specific treatment, little is known about this disease owing to its rarity. OBJECT
Autor:
Shaolei Yan, Haiyong Peng, Qiujie Yu, Xiaodan Chen, Yue Liu, Ye Zhu, Kaige Chen, Ping Wang, Yujiao Li, Xiushi Zhang, Wei Meng
Publikováno v:
Future Oncology. 18:991-1001
Background: To determine suitable optimal classifiers and examine the general applicability of computer-aided classification to compare the differences between a computer-aided system and radiologists in predicting pathological complete response (pCR
Autor:
Charles Coutant, Catherine Loustalot, Marie-Martine Padeano, Laura Vincent, Aurélie Bertaut, Hélène Costaz, K. Peignaux, M. Rouffiac, Isabelle Desmoulins, Delphine Boulle, Clémentine Jankowski, Françoise Beltjens, Sylvain Causeret, Laurent Arnould, Sylvain Ladoire
Publikováno v:
Bulletin du Cancer. 109:268-279
Summary Purpose In the ACOSOG Z0011 trial, patients with primary breast cancer and 1–2 tumor-involved sentinel lymph nodes (SLNs) undergoing breast-conserving surgery had no oncological outcome benefit after axillary lymph node dissection (ALND), d
Autor:
FELIPE TORRES DANTAS, PEDRO HENRIQUE FELIX-SILVA, HÉLIO HUMBERTO ANGOTTI-CARRARA, FRANCISCO JOSE CANDIDO DOS-REIS, MARIO TABA JUNIOR, SÉRGIO LUÍS SCOMBATTI DE-SOUZA, DANIELA BAZAN PALIOTO
Publikováno v:
Anticancer Research. 42:1327-1332
Tumor interstitial fluid (TIF), a component of the tumor microenvironment, is a valuable source of molecules and substances that help in diagnosis and prognosis of solid tumors. There is still no consensus on the optimal method for collecting TIF. Th
Publikováno v:
Anticancer Research. 42:1013-1018
Improvements in acellular dermal matrix (ADM) and surgical techniques have facilitated pre-pectoral immediate breast reconstruction (IBR). Outer shell texturing is a key risk factor for anaplastic large cell lymphoma, prompting this evaluation of rec
Publikováno v:
Anticancer Research
Background/Aim: The aim of this study was to analyze the toxicity of locoregional adjuvant breast cancer radiotherapy after implementation of this service in a rural healthcare region with long travel distance. Patients and Methods: This was a retros
Autor:
Sadaf, Jafferbhoy, Manoj, Gowda S, Kirti Katherine, Kabeer, Zatinahhayu, Mohd-Isa, Seema, Salehi-Bird, Sekhar, Marla, Sankaran, Narayanan, Soni, Soumian
Publikováno v:
Breast Disease. 41:165-173
BACKGROUND AND OBJECTIVES: MRI is generally performed to assess response to Neo-adjuvant systemic therapy (NAST) in breast cancer. OBJECTIVE: To assess role of MRI in determining the probability of having residual disease in patients undergoing NAST.
Publikováno v:
Breast Disease. 41:199-203
BACKGROUND: Breast cancer heterogeneity is well documented and to some extent is attributed to the presence of cancer stem cells (CSCs). Breast cancer stem cells are identified by the presence of cell surface molecule CD44 and absence of CD24. METHOD
Autor:
Keiko, Hosoya, Kanae, Nosaka, Tomohiko, Sakabe, Makoto, Wakahara, Yuki, Oshima, Yoshimasa, Suzuki, Hiroshige, Nakamura, Yoshihisa, Umekita
Publikováno v:
Anticancer Research. 42:279-285
Serglycin plays a crucial role in the aggressiveness of several types of malignancies, including breast cancer. In this study, we aimed to investigate the prognostic impact of serglycin expression in breast cancer patients, which has not been previou